What is Wedbush’s Estimate for Scholar Rock FY2028 Earnings?

Scholar Rock Holding Co. (NASDAQ:SRRK) – Equities research analysts at Wedbush increased their FY2028 earnings estimates for Scholar Rock in a research report issued on Tuesday, November 12th. Wedbush analyst D. Nierengarten now anticipates that the company will post earnings of $0.39 per share for the year, up from their prior forecast of $0.33. Wedbush currently has a “Outperform” rating and a $37.00 target price on the stock. The consensus estimate for Scholar Rock’s current full-year earnings is ($2.37) per share.

Other equities analysts have also recently issued reports about the stock. JPMorgan Chase & Co. boosted their price target on shares of Scholar Rock from $18.00 to $31.00 and gave the company an “overweight” rating in a report on Monday, October 14th. HC Wainwright boosted their price target on Scholar Rock from $35.00 to $40.00 and gave the company a “buy” rating in a research note on Tuesday. Piper Sandler boosted their target price on shares of Scholar Rock from $28.00 to $42.00 and gave the stock an “overweight” rating in a research report on Tuesday, October 15th. Finally, BMO Capital Markets lifted their price objective on shares of Scholar Rock from $34.00 to $38.00 and gave the company an “outperform” rating in a research note on Friday, October 11th. Six investment analysts have rated the stock with a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Buy” and an average target price of $34.00.

Scholar Rock Stock Up 0.3 %

Shares of SRRK traded up $0.07 during trading hours on Thursday, reaching $27.45. The company’s stock had a trading volume of 19,083 shares, compared to its average volume of 1,130,480. The firm has a market cap of $2.20 billion, a price-to-earnings ratio of -11.65 and a beta of 0.47. The company has a quick ratio of 6.04, a current ratio of 6.04 and a debt-to-equity ratio of 0.36. The company has a 50 day moving average of $19.86 and a two-hundred day moving average of $13.43. Scholar Rock has a 1-year low of $6.76 and a 1-year high of $35.38.

Insider Activity at Scholar Rock

In other news, Director Srinivas Akkaraju sold 1,175,713 shares of the business’s stock in a transaction dated Monday, October 7th. The shares were sold at an average price of $29.25, for a total transaction of $34,389,605.25. Following the transaction, the director now owns 5,612,896 shares in the company, valued at approximately $164,177,208. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. In other Scholar Rock news, insider Tracey Sacco sold 30,000 shares of Scholar Rock stock in a transaction on Monday, October 7th. The stock was sold at an average price of $25.62, for a total value of $768,600.00. Following the completion of the transaction, the insider now owns 49,285 shares in the company, valued at approximately $1,262,681.70. The trade was a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Srinivas Akkaraju sold 1,175,713 shares of the stock in a transaction dated Monday, October 7th. The stock was sold at an average price of $29.25, for a total transaction of $34,389,605.25. Following the sale, the director now directly owns 5,612,896 shares in the company, valued at approximately $164,177,208. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 1,415,340 shares of company stock worth $40,666,088 in the last ninety days. 19.20% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Scholar Rock

Several hedge funds and other institutional investors have recently made changes to their positions in the company. ProShare Advisors LLC raised its position in shares of Scholar Rock by 11.7% in the 1st quarter. ProShare Advisors LLC now owns 15,412 shares of the company’s stock valued at $274,000 after acquiring an additional 1,620 shares during the period. Vanguard Group Inc. raised its stake in Scholar Rock by 4.0% during the 1st quarter. Vanguard Group Inc. now owns 2,969,534 shares of the company’s stock worth $52,739,000 after buying an additional 114,550 shares during the period. American International Group Inc. grew its stake in Scholar Rock by 3.0% in the first quarter. American International Group Inc. now owns 28,407 shares of the company’s stock valued at $505,000 after acquiring an additional 834 shares during the period. Hood River Capital Management LLC increased its stake in Scholar Rock by 58.7% during the 1st quarter. Hood River Capital Management LLC now owns 792,047 shares of the company’s stock worth $14,067,000 after purchasing an additional 292,903 shares in the last quarter. Finally, Redmile Group LLC increased its position in shares of Scholar Rock by 0.3% during the first quarter. Redmile Group LLC now owns 6,419,610 shares of the company’s stock worth $114,012,000 after acquiring an additional 17,105 shares in the last quarter. 91.08% of the stock is owned by institutional investors and hedge funds.

Scholar Rock Company Profile

Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery, development, and delivery of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of myostatin that is in Phase 3 clinical trial for the treatment of spinal muscular atrophy; and SRK-181, which has completed Phase 1 clinical trials for the treatment of cancers that are resistant to checkpoint inhibitor therapies, such as anti-PD-1 or anti-PD-L1 antibody therapies.